3/19
10:18 am
vtvt
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT [Yahoo! Finance]
Low
Report
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT [Yahoo! Finance]
3/19
08:30 am
vtvt
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
Medium
Report
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
3/14
11:06 pm
vtvt
vTv Therapeutics Inc. (NASDAQ: VTVT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
vTv Therapeutics Inc. (NASDAQ: VTVT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/13
08:12 am
vtvt
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update [Yahoo! Finance]
3/13
08:00 am
vtvt
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Medium
Report
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
3/4
08:00 am
vtvt
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
High
Report
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
3/1
08:00 am
vtvt
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
Low
Report
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
2/28
08:14 am
vtvt
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund [Yahoo! Finance]
High
Report
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund [Yahoo! Finance]
5/11/2023
04:15 pm
vtvt
vtv therapeutics inc. - class a
BEAT
Report
-5.6%
vtv therapeutics inc. - class a
4/25
04:24 pm
vtvt
Form DEF 14A vTv Therapeutics Inc. For: Jun 11
Neutral
Report
Form DEF 14A vTv Therapeutics Inc. For: Jun 11
4/10
05:11 pm
vtvt
Form S-3 vTv Therapeutics Inc.
Low
Report
Form S-3 vTv Therapeutics Inc.
3/26
04:36 pm
vtvt
Form 8-K vTv Therapeutics Inc. For: Mar 25
Medium
Report
Form 8-K vTv Therapeutics Inc. For: Mar 25
3/22
04:57 pm
vtvt
Form SC 13D/A vTv Therapeutics Inc. Filed by: MacAndrews & Forbes Inc.
Medium
Report
Form SC 13D/A vTv Therapeutics Inc. Filed by: MacAndrews & Forbes Inc.
3/14
08:01 am
vtvt
Form 3 vTv Therapeutics Inc. For: Mar 13 Filed by: Phillips Anne M.
Medium
Report
Form 3 vTv Therapeutics Inc. For: Mar 13 Filed by: Phillips Anne M.
3/14
07:58 am
vtvt
Form 8-K vTv Therapeutics Inc. For: Mar 13
Medium
Report
Form 8-K vTv Therapeutics Inc. For: Mar 13
3/13
07:59 am
vtvt
Form 10-K vTv Therapeutics Inc. For: Dec 31
Medium
Report
Form 10-K vTv Therapeutics Inc. For: Dec 31
3/13
07:52 am
vtvt
Form 8-K vTv Therapeutics Inc. For: Mar 13
Medium
Report
Form 8-K vTv Therapeutics Inc. For: Mar 13
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register